Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMLX compared with RACC: revenue, margins and what each company keeps, and the suppliers and customers both name
AMLX
Amylyx Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
RACC
Research Alliance Corp III
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMLX
Amylyx Pharmaceuticals, Inc.
vs
RACC
Research Alliance Corp III
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMLX, solid
RACC, dashed
Supply-chain overlap
Revenue flow
AMLX: latest quarter is a loss; flow not drawable. RACC: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: AMLX, RACC.
Role chip = supplier or customer
Source: SEC EDGAR
AMLX
Amylyx Pharmaceuticals, Inc.
Change
28.86
▲
+0.63%
· post 29.02
Mkt cap
$3.2B
Revenue
$416,000
Q3 FY24
RACC
Research Alliance Corp III
Change
10.14
▲
+0.42%
· post 10.15
Closed
Oct 30 '26
Mkt cap
$49.0M
Revenue
—
vs
Compare
Closed
Oct 30 '26
AMLX
Amylyx Pharmaceuticals, Inc.
vs
RACC
Research Alliance Corp III
28.86
▲
+0.63%
post 29.02
Price
10.14
▲
+0.42%
post 10.15
$3.2B
Mkt cap
$49.0M
Q3 FY24
$416,000
Revenue
—
Change
Change
AMLX
28.86
▲
+0.63%
vs
RACC
10.14
▲
+0.42%
Closed
Oct 30 '26